CELLECTAR BIOSCIENCES INC (CLRB) Stock Income Statement
NASDAQ:CLRB - US15117F8077 - Common Stock
4.98 USD
0 (0%)
4.97 USD
-0.01 (-0.2%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 38.51M | 51.78M | 38.96M | 28.81M | 24.13M | |||
| Research and Development | 17.52M | 26.14M | 27.27M | 19.22M | 17.59M | |||
| Selling, General, and Administrative Expenses | 20.99M | 25.64M | 11.69M | 9.59M | 6.54M | |||
| Operating Income | -38.51M | -51.78M | -38.96M | -28.81M | -24.13M | |||
| Interest Income/Expense | 9.51M | 7.26M | -3.87M | 150.00K | 0.00 | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -29.01M | -44.52M | -42.83M | -28.66M | -24.12M | |||
| Income Tax | N/A | 66.00K | -60.00K | -60.00K | 0.00 | |||
| Net Income | -29.07M | -44.58M | -42.77M | -28.60M | -24.12M | |||
| EBITDA | -38.26M | -51.49M | -38.77M | -28.66M | -23.98M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -20.56 | -36.52 | -105.00 | -121.61 | -130.35 | |||
| Non GAAP EPS | -9.79 | -2.97 | -2.93 | -4.05 | -4.30 | |||
| Statistics | ||||||||
All data in USD